Artal Group S.A. Infla Rx N.V. Transaction History

Artal Group S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$3.06 - $51.61 $2.52 Million - $42.6 Million	-825,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$31.16 - $48.62 $10.1 Million - $15.8 Million	325,000 Added 65.0%	825,000 $31.2 Million
Q2 2018 Aug 10, 2018	BUY	$27.33 - $41.46 $10.2 Million - $15.5 Million	375,000 Added 300.0%	500,000 $16.1 Million
Q1 2018 May 10, 2018	BUY	$20.21 - $32.0 $2.53 Million - $4 Million	125,000 New	125,000 $3.61 Million

13.8M

12.9K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $72.5M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.